129 related articles for article (PubMed ID: 10592454)
1. The clinical usefulness of liquid human growth hormone (hGH) (Norditropin SimpleXx in the treatment of GH deficiency.
Iyoda K; Moriwake T; Seino Y; Niimi H
Horm Res; 1999; 51 Suppl 3():113-5. PubMed ID: 10592454
[TBL] [Abstract][Full Text] [Related]
2. Norditropin SimpleXx: a liquid human growth hormone formulation, a pen system and an auto-insertion device.
Müller J; Skakkebaek NE; Jacobsen BB; Keller E; Heinrich U; Hartmann K; Hokken-Koelega AC; Delemarre van de Waal HA
Horm Res; 1999; 51 Suppl 3():109-12. PubMed ID: 10592453
[TBL] [Abstract][Full Text] [Related]
3. An open-label acceptability study of Norditropin SimpleXx--a new liquid growth hormone formulation.
Stanhope R; Buchanan C; Butler G; Costigan C; Dunger D; Greene S; Hoey H; Hughes I; Kelnar C; Kirk J; Komulainen J; Lowry M; Warner J
J Pediatr Endocrinol Metab; 2001 Jun; 14(6):735-40. PubMed ID: 11453523
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of Liquid Human Growth Hormone (hGH) [Norditropin Simple Xx®] in Adults and Children with GH Deficiency and Children with Chronic Renal Disease.
Drent ML; Jakobsdottir S; van Wijk JAE; Oostdijk W; Wit JM
Clin Drug Investig; 2002 Sep; 22(9):633-638. PubMed ID: 29492857
[TBL] [Abstract][Full Text] [Related]
6. Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first 3 years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency.
Zenaty D; Garel C; Limoni C; Czernichow P; Léger J
Clin Endocrinol (Oxf); 2003 May; 58(5):647-52. PubMed ID: 12699449
[TBL] [Abstract][Full Text] [Related]
7. A randomised study of two doses of biosynthetic human growth hormone on final height of pubertal children with growth hormone deficiency.
Coelho R; Brook CG; Preece MA; Stanhope RG; Dattani MT; Hindmarsh PC
Horm Res; 2008; 70(2):85-8. PubMed ID: 18547954
[TBL] [Abstract][Full Text] [Related]
8. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
[TBL] [Abstract][Full Text] [Related]
10. Liquid growth hormone: preservatives and buffers.
Kappelgaard AM; Bojesen A; Skydsgaard K; Sjögren I; Laursen T
Horm Res; 2004; 62 Suppl 3():98-103. PubMed ID: 15539807
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
Hwang JS; Lee HS; Chung WY; Han HS; Jin DK; Kim HS; Ko CW; Lee BC; Lee DY; Lee KH; Shin JH; Suh BK; Yoo HW; Ji HJ; Lee JH; Bae YJ; Kim DH; Yang SW
Eur J Endocrinol; 2013 Aug; 169(2):179-85. PubMed ID: 23682096
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
[TBL] [Abstract][Full Text] [Related]
13. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
Kohno H; Murakami Y; Kodaira T
J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
[TBL] [Abstract][Full Text] [Related]
14. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
Saggese G; Federico G; Barsanti S; Fiore L
J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
[TBL] [Abstract][Full Text] [Related]
15. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
Maggio MC; Vergara B; Porcelli P; Corsello G
Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of 20-kilodalton human growth hormone (20K-hGH) for adults with growth hormone deficiency: results of an exploratory uncontrolled multicenter clinical trial of 20K-hGH.
Hayakawa M; Shimazaki Y; Tsushima T; Kato Y; Takano K; Chihara K; Shimatsu A; Irie M
J Clin Endocrinol Metab; 2004 Apr; 89(4):1562-71. PubMed ID: 15070913
[TBL] [Abstract][Full Text] [Related]
17. Final height of growth hormone-treated GH-deficient children and girls with Turner's syndrome: the Dutch experience. The Dutch Advisory Group on Growth Hormone.
de Muinck Keizer-Schrama S; Van den Broeck J; Sas T; Hokken-Koelega A
Horm Res; 1999; 51 Suppl 3():127-31. PubMed ID: 10592457
[TBL] [Abstract][Full Text] [Related]
18. [The immunogenicity and effect of domestic recombinant human growth hormone: serum GH-antibody determination and evaluation].
Li S; Yu Y; An Z; Xiong Z; Yu H
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):77-9, 83. PubMed ID: 12599435
[TBL] [Abstract][Full Text] [Related]
19. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
20. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
